TY - JOUR
T1 - Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Imaging in the Diagnosis and Management of Patients with Vestibular Schwannomas
AU - Dunn, Ian F.
AU - Bi, Wenya Linda
AU - Mukundan, Srinivasan
AU - Delman, Bradley N.
AU - Parish, John
AU - Atkins, Tyler
AU - Asher, Anthony L.
AU - Olson, Jeffrey J.
N1 - Funding Information:
These evidence-based clinical practice guidelines were funded exclusively by the Congress of Neurological Surgeons and the Tumor Section of the Congress of Neurological Surgeons and the American Association of Neurological Surgeons, which received no funding from outside commercial sources to support the development of this document.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - QUESTION 1 What sequences should be obtained on magnetic resonance imaging (MRI) to evaluate vestibular schwannomas before and after surgery? TARGET POPULATION Adults with vestibular schwannomas. RECOMMENDATIONS Initial Preoperative Evaluation Level 3: Imaging used to detect vestibular schwannomas should use high-resolution T2-weighted and contrast-enhanced T1-weighted MRI. Level 3: Standard T1, T2, fluid attenuated inversion recovery, and diffusion weighted imaging MR sequences obtained in axial, coronal, and sagittal plane may be used for detection of vestibular schwannomas. Preoperative Surveillance Level 3: Preoperative surveillance for growth of a vestibular schwannoma should be followed with either contrast-enhanced 3-dimensional (3-D) T1 magnetization prepared rapid acquisition gradient echo (MPRAGE) or high-resolution T2 (including constructive interference in steady state [CISS] or fast imaging employing steady-state acquisition [FIESTA] sequences) MRI. Postoperative Evaluation Level 2: Postoperative evaluation should be performed with postcontrast 3-D T1 MPRAGE, with nodular enhancement considered suspicious for recurrence. QUESTION 2 Is there a role for advanced imaging for facial nerve detection preoperatively (eg, CISS/FIESTA or diffusion tensor imaging)? TARGET POPULATION Adults with proven or suspected vestibular schwannomas by imaging. RECOMMENDATION Level 3: T2-weighted MRI may be used to augment visualization of the facial nerve course as part of preoperative evaluation. QUESTION 3 What is the expected growth rate of vestibular schwannomas on MRI, and how often should they be imaged if a "watch and wait" philosophy is pursued? TARGET POPULATION Adults with suspected vestibular schwannomas by imaging. RECOMMENDATION Level 3: MRIs should be obtained annually for 5 yr, with interval lengthening thereafter with tumor stability. QUESTION 4 Do cystic vestibular schwannomas behave differently than their solid counterparts? TARGET POPULATION Adults with vestibular schwannomas with cystic components. RECOMMENDATION Level 3: Adults with cystic vestibular schwannomas should be counseled that their tumors may more often be associated with rapid growth, lower rates of complete resection, and facial nerve outcomes that may be inferior in the immediate postoperative period but similar to noncystic schwannomas over time. QUESTION 5 Should the extent of lateral internal auditory canal involvement be considered by treating physicians? TARGET POPULATION Adult patients with vestibular schwannomas. RECOMMENDATION Level 3: The degree of lateral internal auditory canal involvement by tumor adversely affects facial nerve and hearing outcomes and should be emphasized when interpreting imaging for preoperative planning. QUESTION 6 How should patients with neurofibromatosis type 2 (NF2) and vestibular schwannoma be imaged and over what follow-up period? TARGET POPULATION Adult patients with NF2 and vestibular schwannomas. RECOMMENDATION Level 3: In general, vestibular schwannomas associated with NF2 should be imaged (similar to sporadic schwannomas) with the following caveats: 1. More frequent imaging may be adopted in NF2 patients because of a more variable growth rate for vestibular schwannomas, and annual imaging may ensue once the growth rate is established. 2. In NF2 patients with bilateral vestibular schwannomas, growth rate of a vestibular schwannoma may increase after resection of the contralateral tumor, and therefore, more frequent imaging may be indicated, based on the nonoperated tumor's historical rate of growth. 3. Careful consideration should be given to whether contrast is necessary in follow-up studies or if high-resolution T2 (including CISS or FIESTA-type sequences) MRI may adequately characterize changes in lesion size instead. QUESTION 7 How long should vestibular schwannomas be imaged after surgery, including after gross-total, near-total, and subtotal resection? TARGET POPULATION Adult patients with vestibular schwannomas followed after surgery. RECOMMENDATION Level 3: For patients receiving gross total resection, a postoperative MRI may be considered to document the surgical impression and may occur as late as 1 yr after surgery. For patients not receiving gross total resection, more frequent surveillance scans are suggested; annual MRI scans may be reasonable for 5 yr. Imaging follow-up should be adjusted accordingly for continued surveillance if any change in nodular enhancement is demonstrated. The full guideline can be found at https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter-5.
AB - QUESTION 1 What sequences should be obtained on magnetic resonance imaging (MRI) to evaluate vestibular schwannomas before and after surgery? TARGET POPULATION Adults with vestibular schwannomas. RECOMMENDATIONS Initial Preoperative Evaluation Level 3: Imaging used to detect vestibular schwannomas should use high-resolution T2-weighted and contrast-enhanced T1-weighted MRI. Level 3: Standard T1, T2, fluid attenuated inversion recovery, and diffusion weighted imaging MR sequences obtained in axial, coronal, and sagittal plane may be used for detection of vestibular schwannomas. Preoperative Surveillance Level 3: Preoperative surveillance for growth of a vestibular schwannoma should be followed with either contrast-enhanced 3-dimensional (3-D) T1 magnetization prepared rapid acquisition gradient echo (MPRAGE) or high-resolution T2 (including constructive interference in steady state [CISS] or fast imaging employing steady-state acquisition [FIESTA] sequences) MRI. Postoperative Evaluation Level 2: Postoperative evaluation should be performed with postcontrast 3-D T1 MPRAGE, with nodular enhancement considered suspicious for recurrence. QUESTION 2 Is there a role for advanced imaging for facial nerve detection preoperatively (eg, CISS/FIESTA or diffusion tensor imaging)? TARGET POPULATION Adults with proven or suspected vestibular schwannomas by imaging. RECOMMENDATION Level 3: T2-weighted MRI may be used to augment visualization of the facial nerve course as part of preoperative evaluation. QUESTION 3 What is the expected growth rate of vestibular schwannomas on MRI, and how often should they be imaged if a "watch and wait" philosophy is pursued? TARGET POPULATION Adults with suspected vestibular schwannomas by imaging. RECOMMENDATION Level 3: MRIs should be obtained annually for 5 yr, with interval lengthening thereafter with tumor stability. QUESTION 4 Do cystic vestibular schwannomas behave differently than their solid counterparts? TARGET POPULATION Adults with vestibular schwannomas with cystic components. RECOMMENDATION Level 3: Adults with cystic vestibular schwannomas should be counseled that their tumors may more often be associated with rapid growth, lower rates of complete resection, and facial nerve outcomes that may be inferior in the immediate postoperative period but similar to noncystic schwannomas over time. QUESTION 5 Should the extent of lateral internal auditory canal involvement be considered by treating physicians? TARGET POPULATION Adult patients with vestibular schwannomas. RECOMMENDATION Level 3: The degree of lateral internal auditory canal involvement by tumor adversely affects facial nerve and hearing outcomes and should be emphasized when interpreting imaging for preoperative planning. QUESTION 6 How should patients with neurofibromatosis type 2 (NF2) and vestibular schwannoma be imaged and over what follow-up period? TARGET POPULATION Adult patients with NF2 and vestibular schwannomas. RECOMMENDATION Level 3: In general, vestibular schwannomas associated with NF2 should be imaged (similar to sporadic schwannomas) with the following caveats: 1. More frequent imaging may be adopted in NF2 patients because of a more variable growth rate for vestibular schwannomas, and annual imaging may ensue once the growth rate is established. 2. In NF2 patients with bilateral vestibular schwannomas, growth rate of a vestibular schwannoma may increase after resection of the contralateral tumor, and therefore, more frequent imaging may be indicated, based on the nonoperated tumor's historical rate of growth. 3. Careful consideration should be given to whether contrast is necessary in follow-up studies or if high-resolution T2 (including CISS or FIESTA-type sequences) MRI may adequately characterize changes in lesion size instead. QUESTION 7 How long should vestibular schwannomas be imaged after surgery, including after gross-total, near-total, and subtotal resection? TARGET POPULATION Adult patients with vestibular schwannomas followed after surgery. RECOMMENDATION Level 3: For patients receiving gross total resection, a postoperative MRI may be considered to document the surgical impression and may occur as late as 1 yr after surgery. For patients not receiving gross total resection, more frequent surveillance scans are suggested; annual MRI scans may be reasonable for 5 yr. Imaging follow-up should be adjusted accordingly for continued surveillance if any change in nodular enhancement is demonstrated. The full guideline can be found at https://www.cns.org/guidelines/guidelines-management-patients-vestibular-schwannoma/chapter-5.
KW - Acoustic neuroma
KW - Advanced imaging
KW - Cystic
KW - Facial nerve
KW - Growth rate
KW - MRI
KW - Vestibular schwannoma
UR - http://www.scopus.com/inward/record.url?scp=85041548594&partnerID=8YFLogxK
U2 - 10.1093/neuros/nyx510
DO - 10.1093/neuros/nyx510
M3 - Article
C2 - 29309686
AN - SCOPUS:85041548594
SN - 0069-4827
VL - 82
SP - E32-E34
JO - Clinical Neurosurgery
JF - Clinical Neurosurgery
IS - 2
ER -